@article{S._G._K._2020, title={Clinico-epidemiological study of topical steroid dependent face in a tertiary care hospital at Mysore}, volume={9}, url={https://www.ijbcp.com/index.php/ijbcp/article/view/4106}, DOI={10.18203/2319-2003.ijbcp20202944}, abstractNote={<p><strong>Background: </strong>Topical steroids are the most commonly prescribed drugs in dermatology. The adverse effects of steroid misuse are noticeable 3 to 4 weeks after application. Steroid rosacea, hypertrichosis and acneiform eruptions are few of them. A new entity known as topical steroid dependent face, topical steroid dependent face (TSDF) has been recently coined to encompass symptoms such as erythema, burning sensation on attempted cessation of topical steroid application.</p><p><strong>Methods:</strong> A questionnaire-based analysis was done among patients attending dermatology outpatient department of government medical college hospital, Mysore between November 2018 to May 2019. Prior approval of the institutional ethics committee, and consent of patients were obtained. A total of 200 outpatients with facial dermatosis using topical steroids on face for a period greater than one month were taken up for study.</p><p><strong>Results:</strong> The results included population across different age groups, between 16 to 60 years. 56% belonged to the age group of 16 to 30 years. Most common steroid abused was mometasone cream 0.1% (50%), betamethasone valerate cream 0.1% (24.5%) followed by clobetasol ointment 0.05% (21.5%). The major adverse effect with steroid abuse, were acne 72% facial redness 67%. Hyperpigmentation 51%, hypertrichosis 32.5% and skin atrophy 21%.</p><p><strong>Conclusions:</strong> The present study highlights and creates awareness on the burden of facial topical steroid abuse and the poor attitude towards them.</p>}, number={7}, journal={International Journal of Basic & Clinical Pharmacology}, author={S., Skandashree B. and G., Hema N. and K., Surendran K. A.}, year={2020}, month={Jun.}, pages={1073–1078} }